BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  NANOBIOTIX Successfully Completes Approximately Eur 27.2M Placement of New Shares

  Funds raised via an accelerated book building offering announced on October 30, 2017.

  October 31, 2017

   · 

  8 min read
• Business

  Basilea’s Chief Medical Officer Prof. Achim Kaufhold to Retire and Dr. Marc Engelhardt Named as Successor

  Dr. Engelhardt joined Basilea in 2010 as Head of Clinical Research.

  October 31, 2017

   · 

  3 min read
• Business

  Horizon Discovery Partners With the Michael J. Fox Foundation to Introduce Novel Pre-Clinical Models for Parkinson’s Disease

  Horizon Discovery introduced two new gene knock-out and knock-in rat models for investigating the role of alpha-synuclein in brain function and Parkinson’s disease (PD) pathogenesis.

  October 31, 2017

   · 

  4 min read
• Cmed to Showcase Advanced Data Insights and Analytics Capabilities of Encapsia Clinical Data Suite At Partnerships in Clinical Trials Europe

  Cmed, an innovative technology-led CRO, will demonstrate its encapsia clinical data suite at Partnerships in Clinical Trials Europe, taking place 28-29 November 2017 in Amsterdam, The Netherlands.

  October 31, 2017

   · 

  2 min read
• Change of Number of Shares and Votes in Karolinska Development

  Today, the last trading day of the month, there are 64,361,206, shares, representing a total of 77,889,088 votes outstanding in the Company, distributed among 1,503,098 shares of series A (with 15,030,980 votes) and 62,858,108 shares of series B (with 62,858,108 votes).

  October 31, 2017

   · 

  1 min read
• Business

  Spring Bank Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2017 Financial and Operational Results

  Quarter highlighted by data presentations at two conferences and the initiation of research collaborations.

  October 31, 2017

   · 

  11 min read
• Business

  Ritter Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update

  The company reported a net loss attributable to common stockholders of approximately $2.0 million compared to a net loss of approximately $3.5 million for the third quarter of 2016.

  October 31, 2017

   · 

  6 min read
• Lone Star Bio

  Invitae Presents Validation of a Novel NGS-based Preimplantation Genetic Screening Technology to Identify the Most Frequent Chromosomal Causes of Miscarriage

  Invitae is presenting validation data for a novel, NGS-based PGS technology that accurately identifies certain chromosomal abnormalities potentially missed on other PGS platforms.

  October 31, 2017

   · 

  6 min read
• Avella Selected by Astra to Distribute CALQUENCE (acalabrutinib)

  CALQUENCE (acalabrutinib), was granted accelerated approval today by the FDA.

  October 31, 2017

   · 

  2 min read
• Business

  3D Systems Reports Third Quarter 2017 Financial Results

  For the third quarter of 2017, the company reported revenue of $152.9M compared to $156.4M in the third quarter of the previous year.

  October 31, 2017

   · 

  26 min read